![]()
There is nothing positive about false positives—
just more testing, more time, more worry.
Fortunately, BNP testing can assist in ruling out heart failure in symptomatic patients, with fewer
false positives than NT-proBNP.
1-2
Bayer’s BNP assay uses widely accepted, very specific
antibodies for a high clinical specificity that correctly excludes CHF >97% of the time.
1
This
means getting the patient out of the line and onto the correct treatment pathway faster, with less
additional diagnostic testing. Backed by Bayer’s family of Immunoassay analyzers, you get fast
turnaround time delivering hundreds of tests per hour to rule out more patients—positively.
Fewer false positives. More confidence. That’s innovation in the real world,
only from Bayer HealthCare.
1. ADVIA Centaur Assay Manual BNP - part # 06300497 Rev C June 2003, Bayer HealthCare LLC, Diagnostics Division, Tarrytown, NY.
2. Based on a comparison of the data presented for the reference populations, as stated in the manufacturers’ instructions for use.
Clinical specificity is calculated from the percentage of patients below the diagnostic cutpoints presented for each assay.
www.bayerdiag.com
©2005 Bayer HealthCare LLC. All rights reserved. Bayer and the Bayer Cross are trademarks of Bayer.
Cardiovascular Menu
BNP
CK-MB
Homocysteine
Myoglobin
Troponin I
What Are Your Heart Failure Tests
Resulting In?
Bayer BNP
% FALSE POSITIVES
On average, assays measuring NT-proBNP
result in 9.3% more false positives than
Bayer’s BNP assays.
2
12
11
10
9
8
7
6
5
4
3
2
1
0
NT-proBNP
Percent (%)
11.97%
2.67%
There is nothing positive about false positives—
just more testing, more time, more worry.
Fortunately, BNP testing can assist in ruling out heart failure in symptomatic patients, with fewer
false positives than NT-proBNP.
1-2
Bayer’s BNP assay uses widely accepted, very specific
antibodi s for a high clinical pecificity that corr c ly exclude CHF >97% of the time.
1
This
means ge ting t e patient ut of the lin and onto the corr ct treatment pathway faster, with less
dditi nal diagnostic testing. Backed b Bayer’s famil of Immunoassay analyzers, you get fa t
turnaround time deliveri g hundreds of tests per hour t ule out more patients—positively.
Fewer false positives. More confidence. That’s innovation in the real world,
only from Bayer HealthCare.
1. ADVIA Centaur Assay Manual BNP - part # 06300497 Rev C June 2003, Bayer HealthCare LLC, Diagnostics Division, Tarrytown, NY.
2. Based on a comparison of the data presented for the reference populations, as stated in the manufacturers’ instructions for use.
Clinical specificity is calculated from the percentage of patients below the diagnostic cutpoints presented for each assay.
www.bayerdiag.com
©2005 Bayer HealthCare LLC. All rights res rv d. Bayer and the Bayer Cross are trademarks of Bayer.
CK-MB
Homocysteine
Myoglobin
Troponin I
What Are Your Heart Failure Tests
Resulting In?
Bayer BNP
% FALSE POSITIVES
On average, assays measuring NT-proBNP
result in 9.3% more false positives than
Bayer’s BNP assays.
2
12
11
10
9
8
7
6
5
4
3
2
1
0
NT-proBNP
Percent (%)
11.97%
2.67%
